# EDGAR Filing Document

**Accession Number:** 0001611746
**File Stem:** 0000000000-25-006212
**Filing Date:** 2025-6
**Character Count:** 3354
**Document Hash:** 35b298195b18a268459bfea08ba551cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006212.hdr.sgml**: 20260113

**ACCESSION NUMBER**: 0000000000-25-006212

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250612

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SciSparc Ltd.
- **CENTRAL INDEX KEY:** 0001611746
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-286099

**BUSINESS ADDRESS:**
- **STREET 1:** 20 RAUL WALLENBERG STREET, TOWER A
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971916
- **BUSINESS PHONE:** 972-3-6103100

**MAIL ADDRESS:**
- **STREET 1:** 20 RAUL WALLENBERG STREET, TOWER A
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6971916

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SciSparc Ltd./ADR
- **DATE OF NAME CHANGE:** 20210129

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Therapix Biosciences Ltd.
- **DATE OF NAME CHANGE:** 20140624
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001013762-25-002218

## Text-Extract

```

                                                             June 12, 2025

Oz Adler
Chief Executive Officer
SciSparc Ltd.
20 Raul Wallenberg Street, Tower A
Tel Aviv 6971916 Israel

       Re: SciSparc Ltd.
           Amendment No. 1 Registration Statement on Form F-3
           Filed June 10, 2025
           File No. 333-286099
Dear Oz Adler:

     We have reviewed your amended registration statement and have the
following
comment(s).

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our April 2,
2025 letter.

Amendment No. 1 to Registration Statement on Form F-3 Filed June 10, 2025
General

1.     We note that you have filed an exhibits-only amendment. Please revise
your
       registration statement to reflect information as of a date reasonably
close to the date of
       filing the registration statement, including:
           the description of the status of the merger with AutoMax Motors
Ltd.;
           the effects of this offering after completion of the merger with
AutoMax Motors
            Ltd.;
           the current shares issued and outstanding;
           the Capitalization section; and
           the Incorporation of Certain Information by Reference section.
 June 12, 2025
Page 2

       Please contact Cara Wirth at 202-551-7127 or Donald Field at
202-551-3680 with
any questions.

                                                        Sincerely,

                                                        Division of Corporation
Finance
                                                        Office of Trade &
Services
cc:   Howard Berkenblit, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._